Acute urinary retention (BPH)
GU-Obstruction · Genitourinary
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Sudden painful inability to void, most often from benign prostatic obstruction; may be precipitated by drugs, constipation, infection or immobility.
Red flags
- Renal impairment/high-pressure retention
- Sepsis
- Post-obstructive diuresis with volume depletion
- Painless retention with neurology (cord/cauda equina)
Assessment
Differential diagnosis
- Prostate cancer obstruction
- Urethral stricture
- Neurogenic bladder
- Constipation
- Clot retention
Investigations
- Bladder scan/ultrasound (residual volume)
- U&E and creatinine (assess for AKI/high-pressure retention)
- Urinalysis and culture
- PSA (after acute episode, not during infection/catheter)
Management
- Immediate urethral catheterisation and record drained volume
- Assess for high-pressure chronic retention (renal impairment/hydronephrosis)
- Treat precipitants (constipation, infection, offending drugs)
- Start an alpha-blocker before trial without catheter
- Monitor for post-obstructive diuresis if large residual/AKI
- Arrange urology follow-up and TWOC
Drugs & doses
Alpha-blocker (tamsulosin) before catheter removal
Analgesia
Antibiotics only if infection present
Consider 5-alpha reductase inhibitor for long-term BPH
Disposition
Discharge with catheter and urology TWOC if uncomplicated; admit if AKI/sepsis.
Complications & pitfalls
- Post-obstructive diuresis
- AKI/high-pressure retention
- UTI
- Bladder decompensation
Exam pearls
- Painless retention with saddle anaesthesia suggests cauda equina
- Monitor urine output after decompression for post-obstructive diuresis
- Alpha-blocker improves the chance of a successful TWOC
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.